[Incidence of hepatocellular carcinoma in chronic infection with hepatitis B].
作者信息
Ntagirabiri Rénovat, Munezero Bélyse, Kaze Hippolyte, Ndirahisha Eugène, Manirakiza Sébastien
机构信息
Centre Hospitalo-Universitaire de Kamenge, Département de Médecine Interne, Bujumbura, Burundi ; Centre des maladies du tube digestif et du foie, Bujumbura, Burundi.
Centre Hospitalo-Universitaire de Kamenge, Département de Médecine Interne, Bujumbura, Burundi.
出版信息
Pan Afr Med J. 2015 Feb 23;20:167. doi: 10.11604/pamj.2015.20.167.6227. eCollection 2015.
Abstract
摘要
相似文献
1
[Incidence of hepatocellular carcinoma in chronic infection with hepatitis B].
Pan Afr Med J. 2015 Feb 23;20:167. doi: 10.11604/pamj.2015.20.167.6227. eCollection 2015.
2
SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
Liver Int. 2005 Apr;25(2):226-35. doi: 10.1111/j.1478-3231.2005.01076.x.
3
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
Cancer. 2015 Oct 15;121(20):3631-8. doi: 10.1002/cncr.29537. Epub 2015 Jul 15.
4
Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
Liver Int. 2005 Apr;25(2):220-5. doi: 10.1111/j.1478-3231.2005.01077.x.
5
Natural history of chronic hepatitis B REVEALed.
J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x.
6
Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.
Liver Int. 2007 Sep;27(7):983-8. doi: 10.1111/j.1478-3231.2007.01546.x.
7
HBsAg seroclearance in chronic hepatitis B: implications for hepatocellular carcinoma.
J Clin Gastroenterol. 2011 Jan;45(1):64-8. doi: 10.1097/MCG.0b013e3181dd558c.
8
A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma.
J Natl Cancer Inst. 2012 May 16;104(10):790-2. doi: 10.1093/jnci/djs168. Epub 2012 Mar 14.
9
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication.
Hepatology. 2018 Oct;68(4):1245-1259. doi: 10.1002/hep.30034. Epub 2018 Jul 10.
10
Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.
Gastroenterology. 2011 Oct;141(4):1240-8, 1248.e1-2. doi: 10.1053/j.gastro.2011.06.036. Epub 2011 Jun 22.
引用本文的文献
1
Demographic, clinical and aetiological characteristics of patients with hepatocellular carcinoma followed between 2012 and 2017 at University Hospital Joseph Raseta Befelatanana, Antananarivo, Madagascar.
Ecancermedicalscience. 2022 Nov 4;16:1466. doi: 10.3332/ecancer.2022.1466. eCollection 2022.
2
Burundi Cancer Care Needs: A Call to Action.
Oncologist. 2020 Dec;25(12):1055-1059. doi: 10.1634/theoncologist.2020-0410. Epub 2020 Sep 10.
3
[Hepatitis B virus genotypes and evolutionary markers in chronic HBsAG patients in Bujumbura].
Pan Afr Med J. 2016 Mar 15;23:95. doi: 10.11604/pamj.2016.23.95.8424. eCollection 2016.
本文引用的文献
1
Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B.
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD002799. doi: 10.1002/14651858.CD002799.pub2.
2
The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective.
Oncologist. 2010;15 Suppl 4:5-13. doi: 10.1634/theoncologist.2010-S4-05.
3
Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
Pathol Biol (Paris). 2010 Aug;58(4):273-7. doi: 10.1016/j.patbio.2010.01.005. Epub 2010 Apr 7.
4
Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso.
Am J Trop Med Hyg. 2010 Mar;82(3):454-8. doi: 10.4269/ajtmh.2010.09-0088.
5
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.
J Clin Oncol. 2009 Mar 20;27(9):1485-91. doi: 10.1200/JCO.2008.20.7753. Epub 2009 Feb 17.
6
[Epidemiology, prevention, screening and diagnosis of hepatocellular carcinoma].
Bull Cancer. 2009 Jan;96(1):35-43. doi: 10.1684/bdc.2009.0791.
7
Hepatocellular carcinoma: epidemiology, risk factors, and screening.
Semin Liver Dis. 2005;25(2):143-54. doi: 10.1055/s-2005-871194.
8
Epidemiology and natural history of hepatocellular carcinoma.
Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):3-23. doi: 10.1016/j.bpg.2004.10.004.
9
Environmental factors and risk for hepatocellular carcinoma.
Gastroenterology. 2004 Nov;127(5 Suppl 1):S72-8. doi: 10.1016/j.gastro.2004.09.018.
10
Primary liver cancer: worldwide incidence and trends.
Gastroenterology. 2004 Nov;127(5 Suppl 1):S5-S16. doi: 10.1053/j.gastro.2004.09.011.
Zotero 插件